- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有5家主力机构披露2026-06-30报告期持股数据，持仓量总计1.26亿股，占流通A股14.31%
- 波段诊断：
-
技术面诊股
诊断结果：3.0技术面打败了17%的股票
技术面评分前10的股票
近期的平均成本为5.11元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为5.11元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.11","date":1793173966,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.10.29","stock":"-1.93","trade":"-1.88","ind":"-2.92"},{"date":"2026.10.28","stock":"0.78","trade":"1.46","ind":"2.02"},{"date":"2026.10.27","stock":"-0.58","trade":"-3.85","ind":"-2.50"},{"date":"2026.10.26","stock":"-3.55","trade":"0.14","ind":"-1.19"},{"date":"2026.10.23","stock":"1.13","trade":"1.64","ind":"2.79"},{"date":"2026.10.22","stock":"-3.29","trade":"-3.34","ind":"-2.96"},{"date":"2026.10.21","stock":"-0.91","trade":"0.13","ind":"-0.82"},{"date":"2026.10.20","stock":"-0.36","trade":"1.00","ind":"-0.14"},{"date":"2026.10.19","stock":"-1.25","trade":"-1.42","ind":"0.13"},{"date":"2026.10.16","stock":"-0.36","trade":"-0.03","ind":"-0.12"},{"date":"2026.10.15","stock":"-1.92","trade":"-1.39","ind":"-2.43"},{"date":"2026.10.14","stock":"-1.20","trade":"-1.41","ind":"-1.97"},{"date":"2026.10.13","stock":"-0.68","trade":"-0.78","ind":"-0.25"},{"date":"2026.10.12","stock":"-2.82","trade":"-2.33","ind":"-2.03"},{"date":"2026.10.09","stock":"2.21","trade":"1.57","ind":"0.17"},{"date":"2026.10.08","stock":"-1.67","trade":"-1.77","ind":"-2.07"},{"date":"2026.09.30","stock":"0.67","trade":"2.11","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.34","trade":"0.13","ind":"0.34"},{"date":"2026.09.28","stock":"-1.32","trade":"-0.49","ind":"-3.44"},{"date":"2026.09.24","stock":"0.50","trade":"-2.45","ind":"-2.34"},{"date":"2026.09.23","stock":"-1.31","trade":"-0.73","ind":"-0.64"}]
石药景峰,深证成指,化学制药指数
压力支撑
该股压力位为5.11元，支撑位为5.05元。
[{"text":"\u538b\u529b\u4f4d","value":"5.11","date":1793203200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.05","date":1793203200,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.7资金面打败了56%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月29日 20:30
| 机构今日流向(万元) | -1411.14 | 机构5日流向(万元) | -1738.30 |
| 机构10日流向(万元) | -6591.02 | 机构20日流向(万元) | -14763.92 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加113.82万股，其中基金数没有增加，主力净增仓3家，有一定的中长期投资价值。
截止2026-06-30，共5家主力机构（基金3家，一般法人2家），持仓量总计12590.23万股，占流通A股14.31%
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有113.82万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有113.82万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.5消息面打败了11%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 湘股三季报亮点凸显，算力产业链高增长
2026-10-27 - 今年前三季度，一上市湘企净利润同比增长超56倍
2026-10-27 - 三季报速递：五家药企营利双增且净利翻倍，医药细分赛
2026-10-26 - 股东追踪|长沙湘江资产管理有限公司等新进石药景峰前
2026-10-25 - 财报速递：石药景峰2026年前三季度净利润153.
2026-10-28 - 石药景峰（截止2026年9月30日）股东人数为34
2026-10-25 - 石药景峰前三季度营业收入3.08亿元，同比增长10
2026-10-25 - 原董秘仅任职5个月就辞任，财务部资金经理“接棒”
2026-09-28 - 石药景峰：董事会第九届董事会第六次会议决议公告
2026-09-27 - 石药景峰：叶湘武及其一致行动人持股降至4.93%
2026-09-15
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-09-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-09-16 |
| 一般消息 | 重大事项 | 关联交易 | 2026-09-09 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-08-18 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2026-08-01 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-30 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-07-15 |
| 一般消息 | 重大事项 | 关联交易 | 2026-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 利好 | 上市变动 | 公司摘帽 | 2026-06-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-28 |
| 一般消息 | 高管变动 | 因董事会换届 | 2026-04-02 |
| 利好 | 上市变动 | 公司摘* | 2026-03-26 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2026-01-24 |
| 利好 | 分红转增 | 10转10股 | 2026-01-13 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 6条 | 0条 | 6条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：6.0行业面打败了82%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2026.10.29","price":"-2.92","value":"-1.88"},{"date":"2026.10.28","price":"2.02","value":"1.46"},{"date":"2026.10.27","price":"-2.50","value":"-3.85"},{"date":"2026.10.26","price":"-1.19","value":"0.14"},{"date":"2026.10.23","price":"2.79","value":"1.64"},{"date":"2026.10.22","price":"-2.96","value":"-3.34"},{"date":"2026.10.21","price":"-0.82","value":"0.13"},{"date":"2026.10.20","price":"-0.14","value":"1.00"},{"date":"2026.10.19","price":"0.13","value":"-1.42"},{"date":"2026.10.16","price":"-0.12","value":"-0.03"},{"date":"2026.10.15","price":"-2.43","value":"-1.39"},{"date":"2026.10.14","price":"-1.97","value":"-1.41"},{"date":"2026.10.13","price":"-0.25","value":"-0.78"},{"date":"2026.10.12","price":"-2.03","value":"-2.33"},{"date":"2026.10.09","price":"0.17","value":"1.57"},{"date":"2026.10.08","price":"-2.07","value":"-1.77"},{"date":"2026.09.30","price":"-0.11","value":"2.11"},{"date":"2026.09.29","price":"0.34","value":"0.13"},{"date":"2026.09.28","price":"-3.44","value":"-0.49"},{"date":"2026.09.24","price":"-2.34","value":"-2.45"},{"date":"2026.09.23","price":"-0.64","value":"-0.73"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 莱美药业 | 86.48% | 29.06% | 5.8分 |
| 2 | 健康元 | 14.37% | 9.10% | 6.5分 |
| 3 | 向日葵 | 9.70% | 0.00% | 4.7分 |
| 4 | 海正药业 | 7.80% | -6.88% | 5.8分 |
| 5 | 恒瑞医药 | 6.67% | 5.70% | 6.8分 |
| 6 | 海辰药业 | 4.03% | 21.77% | 5.6分 |
| 8 | ST人福 | 3.29% | 2.05% | 5.2分 |
| 10 | 健友股份 | 1.01% | -0.25% | 6.0分 |
| 12 | 海欣股份 | -0.60% | -1.88% | 4.1分 |
| 14 | - | -1.00% | 3.58% | 分 |
| 16 | 华特达因 | -1.73% | -1.69% | 5.0分 |
| 18 | 北大医药 | -2.03% | -7.02% | 5.2分 |
| 20 | 海翔药业 | -2.36% | 0.69% | 5.3分 |
| 22 | - | -2.36% | 1.31% | 分 |
| 24 | 华邦健康 | -2.75% | 1.92% | 6.1分 |
| 26 | 华海药业 | -3.11% | -1.43% | 5.4分 |
| 28 | 新和成 | -3.42% | 1.76% | 6.1分 |
| 30 | 恩华药业 | -3.64% | -0.84% | 5.1分 |
| 32 | - | -4.67% | 0.28% | 分 |
| 34 | 百济神州 | -4.80% | -4.16% | 4.8分 |
| 36 | 京新药业 | -5.31% | -1.25% | 5.4分 |
| 38 | 吉贝尔 | -5.38% | -1.06% | 5.6分 |
| 40 | 卫信康 | -6.38% | -1.76% | 5.7分 |
| 42 | 海普瑞 | -6.68% | -0.66% | 5.6分 |
| 44 | - | -6.95% | -5.62% | 分 |
| 46 | 灵康药业 | -7.14% | -13.06% | 5.1分 |
| 48 | 通化金马 | -7.32% | -4.86% | 5.0分 |
| 50 | ST复华 | -7.53% | 4.12% | 4.8分 |
| 52 | 迪哲医药 | -8.08% | -7.31% | 5.5分 |
| 54 | 翰宇药业 | -8.15% | -9.46% | 5.8分 |
| 56 | 华北制药 | -8.28% | -7.72% | 4.5分 |
| 58 | 九典制药 | -8.40% | -1.74% | 5.0分 |
| 60 | 福安药业 | -8.97% | -3.01% | 4.9分 |
| 62 | 奥赛康 | -9.10% | 0.00% | 6.0分 |
| 64 | 东北制药 | -9.41% | -3.56% | 5.0分 |
| 66 | 小方制药 | -9.78% | 1.15% | 4.5分 |
| 68 | 力生制药 | -9.91% | -4.85% | 4.3分 |
| 70 | 辰欣药业 | -10.77% | -3.58% | 4.7分 |
| 72 | 溢多利 | -11.21% | 0.19% | 4.8分 |
| 74 | 川宁生物 | -11.45% | -7.82% | 4.9分 |
| 76 | 千红制药 | -12.10% | -7.12% | 5.2分 |
| 78 | 广济药业 | -12.35% | -3.36% | 4.8分 |
| 80 | 立方制药 | -12.90% | -1.02% | 6.2分 |
| 82 | 鲁抗医药 | -13.14% | -7.42% | 4.6分 |
| 84 | 双鹭药业 | -13.32% | -1.96% | 4.6分 |
| 86 | 易明医药 | -13.35% | -6.01% | 4.6分 |
| 88 | 拓新药业 | -13.90% | -4.10% | 4.5分 |
| 90 | 新天地 | -14.16% | -4.78% | 5.4分 |
| 92 | 奥翔药业 | -14.17% | -1.77% | 4.8分 |
| 94 | 联环药业 | -14.56% | -6.30% | 4.9分 |
| 96 | 丰原药业 | -14.59% | -5.22% | 4.6分 |
| 98 | 东亚药业 | -14.91% | -6.74% | 3.8分 |
| 100 | 仟源医药 | -15.13% | -4.15% | 5.6分 |
| 102 | 凯因科技 | -15.24% | -1.25% | 4.7分 |
| 104 | 石药景峰 | -15.78% | -4.16% | 4.4分 |
| 106 | 汇宇制药 | -15.87% | 0.09% | 4.6分 |
| 108 | 广生堂 | -16.11% | -3.19% | 3.9分 |
| 110 | 罗欣药业 | -16.35% | -4.55% | 4.7分 |
| 112 | 新华制药 | -16.38% | -3.72% | 4.9分 |
| 114 | 西点药业 | -16.90% | -6.20% | 4.2分 |
| 116 | 华纳药厂 | -17.39% | 0.27% | 5.2分 |
| 118 | 博瑞医药 | -17.71% | -2.70% | 4.4分 |
| 120 | 海南海药 | -17.92% | -3.90% | 3.8分 |
| 122 | - | -18.54% | -4.08% | 分 |
| 124 | 盟科药业 | -18.94% | -0.20% | 4.5分 |
| 126 | 津药药业 | -19.15% | -8.09% | 4.9分 |
| 128 | 润都股份 | -19.35% | -3.04% | 5.3分 |
| 130 | 苑东生物 | -19.67% | -7.28% | 4.7分 |
| 132 | 贝达药业 | -20.49% | -1.40% | 5.2分 |
| 134 | 纳微科技 | -20.97% | 2.61% | 5.1分 |
| 136 | 科源制药 | -21.86% | 0.36% | 4.7分 |
| 138 | 普洛药业 | -22.56% | -6.61% | 5.4分 |
| 140 | 国邦医药 | -23.00% | -5.10% | 4.6分 |
| 142 | 键凯科技 | -23.06% | -1.78% | 5.1分 |
| 144 | 宏辉果蔬 | -25.35% | -9.07% | 5.0分 |
| 146 | 艾力斯 | -26.14% | -1.74% | 5.0分 |
| 148 | 美诺华 | -27.00% | -4.38% | 4.8分 |
| 150 | 圣诺生物 | -27.29% | -5.59% | 4.2分 |
| 152 | 花园生物 | -27.64% | -1.95% | 3.9分 |
| 154 | - | -28.42% | -5.14% | 分 |
| 156 | 富祥股份 | -32.27% | -3.01% | 5.1分 |
| 158 | 益方生物 | -34.10% | -8.76% | 4.2分 |
| 160 | 哈药股份 | -41.48% | -4.86% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2012-09-10 | 增持 | 增持 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 申银万国 | 2012-09-10 | 增持 | 增持 |
| 国都证券 | 2012-09-10 | 增持 | - |
| 长江证券 | 2012-09-09 | 增持 | 增持 |
更多>>行业资讯
- 2012-09-13科达机电稳步上涨 3大业务或刺激业绩大增
- 2012-09-13二重重装职工董事辞职及增补职工董事
- 2012-09-13凤凰光学修订<公司章程>部分条款
- 2012-09-13南通锻压：使用募集资金对南通锻压设备（天津）有限公
- 2012-09-13华中数控：重大资产重组进展
- 2012-09-13华西能源：获得中国证监会核准公开发行公司债券批复
- 2012-09-13海源机械：持股5%以上股东减持股份
- 2012-09-13中原内配：通过德国DaimlerAG（戴姆勒有限公
- 2012-09-13杰瑞股份：重大事项停牌
- 2012-09-13航天科技：股票交易异常波动
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 84/218 ， 23/218。
[{"date":"2026-09-30","value":"0.15","vol":"4.74"},{"date":"2026-06-30","value":"0.56","vol":"-0.06"},{"date":"2026-03-31","value":"0.35","vol":"0.46"},{"date":"2025-12-31","value":"-154.16","vol":"-1.74"},{"date":"2025-09-30","value":"-74.84","vol":"1.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.15 | 0.56 | 0.35 | -154.16 | -74.84 |
| 行业(%) | 4.74 | -0.06 | 0.46 | -1.74 | 1.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"64.50","vol":"47.07"},{"date":"2026-06-30","value":"65.17","vol":"49.07"},{"date":"2026-03-31","value":"69.24","vol":"50.10"},{"date":"2025-12-31","value":"62.89","vol":"49.45"},{"date":"2025-09-30","value":"64.64","vol":"48.93"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.50 | 65.17 | 69.24 | 62.89 | 64.64 |
| 行业(%) | 47.07 | 49.07 | 50.10 | 49.45 | 48.93 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 32/218 ， 16/218。
[{"date":"2026-09-30","value":"10.12","vol":"47.15"},{"date":"2026-06-30","value":"10.36","vol":"19.66"},{"date":"2026-03-31","value":"7.42","vol":"23.45"},{"date":"2025-12-31","value":"-9.11","vol":"37.42"},{"date":"2025-09-30","value":"-7.75","vol":"139.36"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
10.12 | 10.36 | 7.42 | -9.11 | -7.75 |
| 行业(%) | 47.15 | 19.66 | 23.45 | 37.42 | 139.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"102.85","vol":"197.05"},{"date":"2026-06-30","value":"118.02","vol":"353.66"},{"date":"2026-03-31","value":"130.84","vol":"48.30"},{"date":"2025-12-31","value":"-153.11","vol":"-23.63"},{"date":"2025-09-30","value":"8.71","vol":"3.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
102.85 | 118.02 | 130.84 | -153.11 | 8.71 |
| 行业(%) | 197.05 | 353.66 | 48.30 | -23.63 | 3.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 85/218 ， 33/218。
[{"date":"2026-09-30","value":"0.19","vol":"0.32"},{"date":"2026-06-30","value":"0.12","vol":"0.21"},{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.43","vol":"0.41"},{"date":"2025-09-30","value":"0.30","vol":"0.30"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.19 | 0.12 | 0.06 | 0.43 | 0.30 |
| 行业(次) | 0.32 | 0.21 | 0.10 | 0.41 | 0.30 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.17","vol":"2.04"},{"date":"2026-06-30","value":"1.57","vol":"1.30"},{"date":"2026-03-31","value":"0.89","vol":"0.65"},{"date":"2025-12-31","value":"3.38","vol":"2.59"},{"date":"2025-09-30","value":"2.01","vol":"1.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.17 | 1.57 | 0.89 | 3.38 | 2.01 |
| 行业(次) | 2.04 | 1.30 | 0.65 | 2.59 | 1.94 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"78.40","vol":"11.02"},{"date":"2026-06-30","value":"-56.54","vol":"5.40"},{"date":"2026-03-31","value":"-66.52","vol":"-2.46"},{"date":"2025-12-31","value":"27.37","vol":"15.44"},{"date":"2025-09-30","value":"36.07","vol":"4.53"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 78.40 | -56.54 | -66.52 | 27.37 | 36.07 |
| 行业 | 11.02 | 5.40 | -2.46 | 15.44 | 4.53 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"4.87","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.14","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 4.87 | - | 0.14 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.59 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 88/218 ， 91/218。
[{"date":"2026-09-30","value":"4.77","vol":"3.21"},{"date":"2026-06-30","value":"5.04","vol":"3.68"},{"date":"2026-03-31","value":"4.47","vol":"3.65"},{"date":"2025-12-31","value":"0.34","vol":"3.44"},{"date":"2025-09-30","value":"0.39","vol":"3.52"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.77 | 5.04 | 4.47 | 0.34 | 0.39 |
| 行业 | 3.21 | 3.68 | 3.65 | 3.44 | 3.52 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"4.55","vol":"2.54"},{"date":"2026-06-30","value":"4.84","vol":"2.98"},{"date":"2026-03-31","value":"4.36","vol":"3.01"},{"date":"2025-12-31","value":"0.28","vol":"2.82"},{"date":"2025-09-30","value":"0.30","vol":"2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.55 | 4.84 | 4.36 | 0.28 | 0.30 |
| 行业 | 2.54 | 2.98 | 3.01 | 2.82 | 2.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 79/218 ， 80/218。
[{"date":"2026-09-30","value":"17.40","vol":"32.93"},{"date":"2026-06-30","value":"16.58","vol":"33.24"},{"date":"2026-03-31","value":"18.86","vol":"32.97"},{"date":"2025-12-31","value":"103.45","vol":"34.15"},{"date":"2025-09-30","value":"104.30","vol":"33.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.40 | 16.58 | 18.86 | 103.45 | 104.30 |
| 行业(%) | 32.93 | 33.24 | 32.97 | 34.15 | 33.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.21","vol":"0.69"},{"date":"2026-06-30","value":"0.19","vol":"0.70"},{"date":"2026-03-31","value":"0.23","vol":"9.64"},{"date":"2025-12-31","value":"36.65","vol":"1.73"},{"date":"2025-09-30","value":"24.55","vol":"1.17"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.21 | 0.19 | 0.23 | 36.65 | 24.55 |
| 行业(%) | 0.69 | 0.70 | 9.64 | 1.73 | 1.17 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-1.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.36","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.81","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]